| Literature DB >> 18295565 |
Abstract
A European law that prevents the patenting of discoveries that contravene morality is causing confusion when it comes to human embryonic stem cells. The ensuing debate is markedly different from the one in the United States, where the scope of stem cell patents and their licensing are under challenge.Entities:
Mesh：
Year: 2008 PMID： 18295565 DOI： 10.1016/j.cell.2008.02.012
Source DB: PubMed Journal: Cell ISSN： 0092-8674 Impact factor: 41.582